33.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer - Insider Monkey
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Can trapped investors hope for a rebound in Viking Therapeutics Inc.Bond Market & Smart Investment Allocation Insights - newser.com
How to integrate Viking Therapeutics Inc. into portfolio analysis toolsStop Loss & High Conviction Investment Ideas - newser.com
Live market analysis of Viking Therapeutics Inc.2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedWeekly Risk Summary & Technical Analysis for Trade Confirmation - Trung tâm Dự báo KTTV quốc gia
Why Viking Therapeutics Inc. stock attracts high net worth investorsJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? - Yahoo Finance
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics - sharewise.com
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street? - sharewise.com
Earnings Preview: VKTX to Report Financial Results Post-market on October 22 - 富途牛牛
What to expect from Viking Therapeutics Inc. in the next 30 days2025 Valuation Update & Precise Buy Zone Tips - newser.com
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? - MSN
How hedge fund analytics apply to Viking Therapeutics Inc. stockPortfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Advances Through Late-Stage Obesity Drug Trials - simplywall.st
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? - sharewise.com
Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025 - The Malaysian Reserve
Q3 2025 Results on Oct. 22 — Viking Therapeutics to Host Conference Call and Webcast - Stock Titan
Sector ETF performance correlation with Viking Therapeutics Inc.2025 Price Momentum & Low Risk Entry Point Guides - newser.com
How to build a custom watchlist for Viking Therapeutics Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Is a relief rally coming for Viking Therapeutics Inc. holdersNew Guidance & AI Powered Market Trend Analysis - newser.com
Can Viking Therapeutics Inc. stock hit record highs againJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
Using data models to predict Viking Therapeutics Inc. stock movement2025 Trading Recap & Reliable Volume Spike Trade Alerts - newser.com
Visualizing Viking Therapeutics Inc. stock with heatmapsJuly 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
Will Progress in VK2735 Weight Loss Trials Change Viking Therapeutics' (VKTX) Narrative? - simplywall.st
Chart based exit strategy for Viking Therapeutics Inc.Portfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Why Shares in Viking Therapeutics Surged This Week - MSN
Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&D expenses - Investing.com
What makes Viking Therapeutics Inc. stock attractive to growth fundsJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Down 44%, Should You Buy the Dip on Viking Therapeutics? - sharewise.com
Key metrics from Viking Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Viking Therapeutics Inc. stock volume spike explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):